| Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation E Fokas, R Prevo, JR Pollard, PM Reaper, PA Charlton, B Cornelissen, ... Cell death & disease 3 (12), e441-e441, 2012 | 448 | 2012 |
| Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 E Fokas, M Allgäuer, B Polat, G Klautke, GG Grabenbauer, R Fietkau, ... Journal of Clinical Oncology 37 (34), 3212-3222, 2019 | 407 | 2019 |
| Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized … H Golcher, TB Brunner, H Witzigmann, L Marti, WO Bechstein, C Bruns, ... Strahlentherapie und Onkologie 191 (1), 7, 2015 | 318 | 2015 |
| ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in … J Hoeppner, F Lordick, T Brunner, T Glatz, P Bronsert, N Röthling, ... BMC cancer 16, 1-10, 2016 | 310 | 2016 |
| The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy R Prevo, E Fokas, PM Reaper, PA Charlton, JR Pollard, WG McKenna, ... Cancer biology & therapy 13 (11), 1072-1081, 2012 | 263 | 2012 |
| Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography KA Miles, TY Lee, V Goh, E Klotz, C Cuenod, S Bisdas, AM Groves, ... European radiology 22, 1430-1441, 2012 | 260 | 2012 |
| Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling TS Mantoni, S Lunardi, O Al-Assar, A Masamune, TB Brunner Cancer research 71 (10), 3453-3458, 2011 | 247 | 2011 |
| Targeting ATR in DNA damage response and cancer therapeutics E Fokas, R Prevo, EM Hammond, TB Brunner, WG McKenna, RJ Muschel Cancer treatment reviews 40 (1), 109-117, 2014 | 227 | 2014 |
| Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations TB Brunner, SM Hahn, AK Gupta, RJ Muschel, WG McKenna, ... Cancer research 63 (18), 5656-5668, 2003 | 201 | 2003 |
| The stromal compartments in pancreatic cancer: are there any therapeutic targets? S Lunardi, RJ Muschel, TB Brunner Cancer letters 343 (2), 147-155, 2014 | 198 | 2014 |
| Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging MO Leach, B Morgan, PS Tofts, DL Buckley, W Huang, MA Horsfield, ... European radiology 22, 1451-1464, 2012 | 183 | 2012 |
| Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer TB Brunner, M Geiger, GG Grabenbauer, M Lang-Welzenbach, ... Journal of Clinical Oncology 26 (16), 2699-2706, 2008 | 175 | 2008 |
| Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers KJ Harrington, LJ Billingham, TB Brunner, NG Burnet, CS Chan, P Hoskin, ... British journal of cancer 105 (5), 628-639, 2011 | 171 | 2011 |
| Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ... JAMA oncology 8 (1), e215445-e215445, 2022 | 169 | 2022 |
| ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams L Wilke, N Andratschke, O Blanck, TB Brunner, SE Combs, AL Grosu, ... Strahlentherapie und Onkologie 195 (3), 193-198, 2019 | 165 | 2019 |
| Stereotactic body radiotherapy for liver tumors F Sterzing, TB Brunner, I Ernst, WW Baus, B Greve, K Herfarth, ... Strahlentherapie und Onkologie 190 (10), 872, 2014 | 153 | 2014 |
| Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial U Nestle, T Schimek-Jasch, S Kremp, A Schaefer-Schuler, M Mix, ... The Lancet Oncology 21 (4), 581-592, 2020 | 149 | 2020 |
| The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver … N Andratschke, H Alheid, M Allgäuer, G Becker, O Blanck, ... BMC cancer 18, 1-11, 2018 | 138 | 2018 |
| Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1 N Cordes, S Frick, TB Brunner, C Pilarsky, R Grützmann, B Sipos, ... Oncogene 26 (48), 6851-6862, 2007 | 136 | 2007 |
| Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma TS Mantoni, RRE Schendel, F Rödel, G Niedobitek, O Al-Assar, ... Cancer biology & therapy 7 (11), 1806-1815, 2008 | 129 | 2008 |
Gillies McKennaOxford Institute for Radiation OncologyVerified email at oncology.ox.ac.uk
